UK DH "confident for the NHS in the face of the economic downturn"
This article was originally published in Clinica
In the face of the economic downturn, the UK government today said it was well placed to address the NHS' operational and supply funding needs. A predicted surplus of £1.73bn ($2.66bn) "will stay within the NHS and will be used to improve patient care", said the DH, citing its second-quarter (June-September 2008) performance report, published today. The DH is also forecasting a gross operating deficit of £86m at year-end, down from £125m at the end of 2007-08. Although the NHS, along with the rest of the public sector, "will have to make its contribution to delivering greater efficiency", the DH is "confident that [it is] well placed for the challenges ahead", said David Flory, director general for NHS Finance, Performance and Operations.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.